2018
DOI: 10.1111/add.14430
|View full text |Cite
|
Sign up to set email alerts
|

Varenicline versus placebo for waterpipe smoking cessation: a double‐blind randomized controlled trial

Abstract: Varenicline was not more effective than placebo in aiding cessation of tobacco use in long-term daily waterpipe smokers.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 48 publications
0
3
0
1
Order By: Relevance
“…Additionally, we offered behavioral support to all participants (28). Upon receipt of the recruitment, researchers contact participants to schedule a face-to-face individual informal meeting, which aims to enhance the awareness of the dangers and benefits of smoking cessation, determine a quit date, explain common withdrawal symptoms and advice appropriate methods for relief.…”
Section: Procedures and Treatmentmentioning
confidence: 99%
“…Additionally, we offered behavioral support to all participants (28). Upon receipt of the recruitment, researchers contact participants to schedule a face-to-face individual informal meeting, which aims to enhance the awareness of the dangers and benefits of smoking cessation, determine a quit date, explain common withdrawal symptoms and advice appropriate methods for relief.…”
Section: Procedures and Treatmentmentioning
confidence: 99%
“…Waterpipe smoking cessation rates were higher in the intervention groups in all three studies. In addition, one double-blind randomised controlled study conducted by DOGAR et al [59] tested the efficacy of varenicline in achieving abstinence from all tobacco use among waterpipe smokers. This study included two parallel groups with a total number of 510 waterpipe smokers randomised for either varenicline or placebo who were followed for a period of 25 weeks post-randomisation.…”
Section: Addiction and Smoking Cessationmentioning
confidence: 99%
“…У дослідженні О. Dogar та співавт. не було показано достовірної різниці щодо відмови від кальяну в групах варенікліну, який широко застосовують для лікування тютюнопаління (12 із 253; 4,7 %), та плацебо (11 із 257; 4,3 %) (ВР 1,11; 95% ДІ 0,50-2,47; Р = 0,80) [62].…”
Section: припинення паління кальянуunclassified